In the Name of GOD L iver Masses General Overview Behzad Nakhai, M.D.,FICS Fellowship in HepatoBiliary Surgery Asso Professor Iran University of Medical.

Slides:



Advertisements
Similar presentations
Michael Brillantes, MD, FPCS, FPSGS
Advertisements

Interventional Oncology Michael Kotton MD October 27, 2012.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 5 The Liver Part I: Abdominal Sonography Abdomen and Superficial Structures.
Hepatobiliary Anatomy and Pathology
Liver Cancer ACC RNSG Risk factors 4 th most common cancer in the world Most common primary liver cancer is hepatocellular carcinoma Cirrhosis –
Ayman Abdo MD, AmBIM, FRCPC
Cancers of the liver and pancreas
Risk factors 4 th most common cancer in the world Cirrhosis – primary risk factor Other risk factors: hepatitis C and B Metastatic – more common than.
Tumors of the bile ducts
Tumours of the liver John J O’Leary.
Sef lucrari Dr. Carmen Anton
Hepatobiliary pathology By Dr/ Dina Metwaly
Colorectal cancer Khayal AlKhayal MD,FRCSC
Liver surgery AnatomyHepatectomy Liver tumors BenignMalignant.
Chapter 12 Liver, Gallbladder, and Pancreas Diseases and Disorders
Malignant focal liver lesions
CASE PRESENTATION By: Dr. SHAMSHAD KHAN TMO Radiology HMC.
Small Bowel Tumors Keith D. Lillemoe M.D. Dept. of Surgery
Consultant Radiologist Prince Sultan Military Medical City
Neoplasia I Walter C. Bell, M.D..
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
Fallopian Tube and Ovarian Malignancy Schwartz's Principles of Surgery Chapter 41. Gynecology.
Cholestatic liver diseases:
Guzman, Alexander Joseph Hipolito, April Lorraine
Faculty of allied medical sciences
Case Report Patient PP Submitted by:Matthew Clower, MSIV Faculty:Sandra Oldham, MD Date:29 August 2007 Radiological Category:Principal Modality (1): Principal.
Hepatocellular Carcinoma (HCC). Definition : Hepatocellular carcinoma is a primary malignancy of the hepatocyte, also known as liver cell carcinoma. Types.
Gallbladder & bile duct Carcinoma Dr. m. h.khosravi.
Introduction to Cancer
Principles of Surgical Oncology Salah R. Elfaqih.
Case Report # 1 Submitted by:James Korf, MS4 Faculty reviewer:Sandra Oldham, MD Date accepted:27 August 2014 Radiological Category:Principal Modality (1):
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
Principles of Surgical Oncology Done by : 428 surgery team surgery team.
HEPATIC TUMORS Dr.Cengiz Pata Gastroenterology Department Yeditepe University,Istanbul.
Pancreatic cancer.
SB Tumor Mazen M. Hassanain. Introduction 1-3% of GI malignancy. 1-3% of GI malignancy. Benign lesion in autopsy 0.2%, 15 times more than the OR incidence.
Liver Cancer  A leading cause of death in the world  Can be primary or a metastatic site  Seen more in other parts of the world  incidence African.
Hepatocellular carcinoma related to Hbv and Hcv
LIVER DISEASES Shanghai Jiaotong University Medical School Renji Hospital Luo meng.
Student SYB Chet Cunha MS IV January 22, History 61 y/o M with known HCV x 5 yrs. presenting with vague abdominal discomfort. Outside CT showed.
Principles of Surgical Oncology
Lecture # 42 NEOPLASIA - 3 Dr
“Hepatocellular Carcinoma” (HCC) By Faiza Asghar.
Clinical History Patient presents with a palpable upper abdominal mass Patient states possible clinical history of abdominal hernia.
It is essential to obtain the exact history of the hypersalivation as well as a thorough and complete past medical history. Oral evaluation should be performed,
Eun Sun Jang, M.D., Ph.D Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine Diseases.
Digestive system Diagnostic imaging department of xuzhou medical college of xuzhou medical college.
 Macroscopic anatomy › External view › The quadrate lobe belongs anatomically to the right lobe and functionally to the left
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
Imaging of Focal Nodular Hyperplasia: A Review
Michael J. Campbell, MD Virginia Mason Medical Center Seattle, Washington.
Third Lecture of Hepatobiliary Lectures Dr. Noori H. Jassim Assistant Professor and Consultant General and GI Surgeon 1.Liver Tumors 2.Liver transplantation.
Gallbladder Cancer Surgical Management
Dr. Ashraf Abdelfatah Faculty of Medicine
MR of Liver imaging :How I do it? AFIIM -ISRA 2016 MR of Liver imaging: How I do it? Laurence BARANES, Pierre ZERBIB, Frédéric PIGNEUR, Alain LUCIANI,
Liver mass Mazen Hassanain. Radiology Arterial enhancement: adenoma, FNH, hemangioma, HCC, NET mets Portal enhancement: CRC liver mets.
Liver Cancer.
Focal nodular hyperplasia
Nodules & Tumors Nodular Hyperplasia non-cirrhotic liver nodules
Radiology of hepatobiliary diseases
Pancreatic cancer Ayman Hasan Linjawi, MD, FRCSC,
NESIR case presentation
Principles of Surgical Oncology
CT of the abdomen.
Cancer Cancer – A general term for more than 250 diseases characterized by abnormal and uncontrolled growth of cells.
Carcinoma of the Liver By: Renee Alta.
Dr Amit Gupta Associate Professor Dept of Surgery
Chapter 14 Hepatic Tumors, Malignant 1
Presentation transcript:

In the Name of GOD L iver Masses General Overview Behzad Nakhai, M.D.,FICS Fellowship in HepatoBiliary Surgery Asso Professor Iran University of Medical Sciences Tehran, Islamic Republic of Iran

Liver Masses In General n Liver Cystic Masses n Liver Benign Masses n Liver Metastatic Masses n Liver Malignant Masses

Liver in General Liver in General n 1/50 of total body weight n Its Size reflects complexity of its Function n 8 Segments through (Cantlie Line) n 75% Portal vein & 25% Hepatic artery n 80% Removal = Normal life n Total Hepatic Blood Flow: – (1500cc / Min / 1.73 m2 of body surface)

Metabolic Functions of the Liver n Glucose production & storage n Urea formation (amino acid metabolism) n Synthesis of proteins & clotting factors n Detoxification of drugs & other substance n Bile acid & Bilirubin production

Types of Liver Cells Types of Liver Cells n Hepatocytes – { Parenchymal cells } n Macrophages – { Kupffer cells }

Benign Lesions of the Liver I Benign Lesions of the Liver Introduction n Are Common n Diagnostic Difficulty with Malignancy n Unknown Etiology ( May be Congenital ) n Necrosis,Thrombosis,Haemorrhage,Rupture n L.F.T are Normal n US & CT Scan are Diagnostic n Biopsy rarely indicated n Diagnostic Laparascopy is now available n Lesions may be Cystic or Solid

Benign Lesions of the Liver Liver Cysts n Degenerative Cyst n Dermoid Cyst n Lymphatic Cyst n Endothelial Cyst n Retention Cyst n Proliferative cyst –Cystadenomas n Parasitic Cysts –Hydatid Cyst –Amebic Cyst

Benign Lesions of the Liver Benign Liver Tumors Benign Lesions of the Liver Benign Liver Tumors n Hamartoma n Adenoma n Focal Nodular Hyperplasia n Hemangioma

Benign Liver Tumors Hamartoma n Composed from normal Liver tissues n Mesenchymal Hamatomas may be rapidly growing in children n Firm, Nodular & Surface location n May be Solitary or Multiple n Malignant Transformation do not occur

Benign Liver Tumors Adenoma Benign Liver Tumors Adenoma n Is seen with Oral Contraceptive n 60-80% with Mestranol n May developed during Pregnancy n Adenomatosis may seen n Severe Pain or Mass effect may occur n Malignant Transformation occur n Liver Resection / Liver Transplantation is indicated

Benign Liver Tumors Focal Nodular Hyperplasia n Occurs in Women in Reproductive age n HyperVascular Pattern in Angiogram n Patients are Asymptomatic n Possible precursor to HCC n Resection is indicated only for Symptomatic FNH

Benign Liver Tumors Hemangioma n Most common benign tumor of Liver n Is seen in the 3rd to 5rd decades n Are less than 5 cm in diameter n May be Single or Multiple n Usually are Asymptomatic n Complications are rare n May be Cavernous & Lobulated n Malignant transformation do not occur n Liver Resection rarely indicate

Malignant Liver Tumors Origin n From liver Cells:HCC, Fibrolamellar Ca n From Biliary Cells : ICCA n From Mesodermal Cells:Angiosarcoma,Sarcoma

Malignant Liver Tumors Hepatocelluler Carcinoma( HCC ) Malignant Liver Tumors Hepatocelluler Carcinoma( HCC ) n 90% of all Primary Liver Malignancy n 4Th Malignancy in the world n Common in Asia & Africa n More common in Males May seen even in Children May seen even in Children

Hepatic Primary Malignancies Malignant Liver Tumors Risk Factor of HCC n Cirrhosis due to : HCV,HBV,Hemochromatosis n Alcoholic & Postnecrotic Cirrhosis n Aflatoxin Longstanding Toxemia n Parasite Infestation of Clonorchis (ICCA)

Malignant Liver Tumors Pathology of HCC Malignant Liver Tumors Pathology of HCC n Hepatocellular Ca –Hepatocytes n Hepatoblastoma –Immature Hepatocyte n Fibrolamellar Ca –Eosinophili Hepatocyte n n Small HCC (< 2 Cm) n Unifocal Expansive n Infiltrating n Multifocal n Vascular Invasion

Malignant Liver Tumors Diagnosis of HCC Malignant Liver Tumors Diagnosis of HCC n Ultrasonography n Serial Alpha _ Fetoprotein n Alkaline phosphatase n Hepatic Arteriography n Liver Isotope Scan n CT & MRI

Malignant Liver Tumors Clinical Presentation of HCC Malignant Liver Tumors Clinical Presentation of HCC n Weight loss & Weakness 80 % n Abdominal Pain & Fullness 50% n Portal Hypertension n Jaundice % n Hypoglycemic Interval n Ascites

Malignant Liver Tumors Fibrolamellar Carcinoma Malignant Liver Tumors Fibrolamellar Carcinoma n Occur in Western Hemisphere n Younger Age 20 to 35 years n More common in Lt Lobe n Occur in Normal Liver n Better prognosis than HCC n Better Response to Surgery

Malignant Liver Tumors IntraHepatic CholangioCarcinoma n Rare Tumour n Normal underlying Liver n May seen in Caroli & PSC n May be local or diffuse n Have a poor Prognosis

Malignant Liver Tumors AngioSarcoma n Most frequent Sarcoma of the liver n 1% of All Primary Malignancy of Liver n Involved Entire liver n An Association with( Anabolic Steroids,Estrogens,OCP ) n Male to Female 3/1 n Age Time Of Diagnosis 50_ 70 n May Progress to Haemangioendothelioma n Poor Prognosis

Malignant Liver Tumors Treatment Options of HCC n Liver Resection n Liver Transplantation n Systemic Chemotherapy ? n TransArterial Embolization ( Lipiodol) n Percutaneous Ethanol Injection n CryoSurgery ( liquid Nitrogen ) n Radiation Therapy ? n RF I.T. T

Hepatic Metastatic Neoplasms B. Nakhaei, M.D n Most Common Malignancy of the Liver n 1/20 Primary to Secondary n Liver is Second only to Regional lymph nodes n 25%_ 50% of dying patients have Liver Metastasis n Mitotic count of Metastasis is 5 times greater than Primary Lesion

Routes of Metastasis to the Liver n Portal Circulation n Lymphatic spread n Hepatic Arterial System n Direct Extension

Liver Metastasis Clinical Manifestations : n Hepatic pain n Ascites n Jaundice n Anorexia n Weight loss n Hepatic nodularity n Audible friction rub n Portal hypertension n Flushing Syndrome

Liver Metastasis Timing of Appearance n Precocious ( Carcinoid of the Ileum) n Synchronous ( Most GI Cancers ) n Metachronous ( Ocular Melanoma)

Liver Metastasis Surgical treatment if : n Control of primary tumor n No systemic or intra- abdominal Metastases n Good patient,s condition n Extent of hepatic involvement n No more than 4 metastases n Primaries in Colon & Rectum & Wilms, n Debulking for other tumor ( ovary, stomach, breast, cervix,.... )

References n HepatoBiliary & Pancreatic Surgery –James Garden 2th Edition 2001 n Principles of Surgery –Schwartz 7th Edition 1999 n ACS Surgery 2001 n Text Book of Surgery –Sabiston 16Th Edition 2001 n B, Nakhaei, M.D.